Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CPA1 | P15085 | 7/20 | 0.59 |
| ▸ | CPA3 | P15088 | 3/20 | 0.57 |
| ▸ | CPB1 | P15086 | 1/20 | 0.57 |
| ▸ | CPB2 | Q96IY4 | 1/20 | 0.57 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.54 |
| ▸ | MME | P08473 | 2/20 | 0.50 |
| ▸ | FOLH1 | Q04609 | 2/20 | 0.49 |
| ▸ | ANPEP | P15144 | 1/20 | 0.48 |
| ▸ | RNPEP | Q9H4A4 | 1/20 | 0.48 |
| ▸ | DNPEP | Q9ULA0 | 1/20 | 0.48 |
| ▸ | SLC1A3 | P43003 | 1/20 | 0.45 |
| ▸ | SLC1A2 | P43004 | 1/20 | 0.45 |
| ▸ | SLC1A1 | P43005 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7290672 | 0.81 | CYP1A2 (0.61) | CPA1CPA3CPB1CPB2CYP1A2 | |
| SCHEMBL7272157 | 0.81 | CYP1A2 (0.61) | CPA1CPA3CPB1CPB2CYP1A2 | |
| SCHEMBL9554487 | 0.80 | CPA1 (0.64) | CPA1CPA3CPB1CPB2CYP1A2 | |
| SCHEMBL9554494 | 0.80 | CPA1 (0.64) | CPA1CPA3CPB1CPB2CYP1A2 | |
| SCHEMBL10076047 | 0.78 | CPA1 (0.70) | CPA1CPA3CPB1CPB2CYP1A2 | |
| SCHEMBL7286651 | 0.77 | CPA1 (0.59) | CPA1CPA3CPB1CPB2CYP1A2 | |
| SCHEMBL9820177 | 0.77 | CPA1 (0.59) | CPA1CPA3CPB1CPB2CYP1A2 | |
| SCHEMBL7278058 | 0.76 | CPA1 (0.71) | CPA1CPA3CPB1CPB2CYP1A2 | |
| SCHEMBL9222947 | 0.76 | CPA1 (0.71) | CPA1CPA3CPB1CPB2CYP1A2 | |
| SCHEMBL9554964 | 0.76 | CPA1 (0.71) | CPA1CPA3CPB1CPB2CYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5063208-A | Cardiovascular disorders, vision defects | ABBOTT LABORATORIES (US) | 1991-11-05 | — | — | US | disclosed |
| EP-0416393-A1 | Peptidyl difluorodiol renin inhibitors | ABBOTT LABORATORIES (US) | 1991-03-13 | — | — | EP | disclosed |
| EP-0410260-A2 | Peptidyl aminodiol renin inhibitors | ABBOTT LABORATORIES (US) | 1991-01-30 | — | — | EP | disclosed |
| WO-1989010751-A1 | FUNCTIONALIZED PEPTIDYL AMINODIOLS AND -TRIOLS | ABBOTT LABORATORIES (US) | 1989-11-16 | — | — | WO | disclosed |
| EP-0341602-A2 | Renin-inhibiting functionalized peptidyl aminodiols and - triols | ABBOTT LABORATORIES (US) | 1989-11-15 | — | — | EP | disclosed |
| EP-0307837-A2 | Renin-inhibiting peptidyl heterocycles | ABBOTT LABORATORIES (US) | 1989-03-22 | — | — | EP | disclosed |